Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c
- PMID: 18465327
- DOI: 10.1080/02841860701851871
Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c
Abstract
Introduction: The tissue microarray (TMA) technique comprises the potential of significantly reducing time and tissue spent on slicing and performing immunohistochemical (IHC) stainings of paraffin-embedded tumor tissue. Tissue heterogeneity is an argument against using TMAs, which has been dealt with by increasing the size and number of cores punched from each tumor. No consensus exists on the most optimal size, number, and position of TMA cores in the donor paraffin block and no information exist regarding agreement between TMA cores from two different paraffin blocks from the same tumor or between TMA cores and biochemical analyses.
Patients and methods: A central and a peripheral 1mm core and a whole section from each of 54 paraffin blocks from 27 breast cancers included in a one-institution cohort, and a single 1mm central TMA core, from each breast tumor from 1000 patients included in the DBCG82 b&c trials, were IHC stained for ER, PgR and HER2. In addition, ER and PgR were measured in the DBCG82 b&c trials by a biochemical analysis. Statistical analyses included Kappa statistics, Kaplan-Meier survival curves, Log-rank tests, and Cox regression hazards analyses.
Results and conclusion: IHC stainings for ER, PgR, and HER2 showed a substantial agreement between a single 1mm TMA core and the corresponding whole section, between central and peripheral cores, and between cores from two different paraffin blocks from the same tumor. In addition, a fine agreement was found for ER and PgR between IHC stainings of TMA cores and biochemical analyses. Divergence between IHC and biochemical analyses was predominantly due to the chosen thresholds. IHC staining of one 1mm core from each tumor revealed a significant independent prognostic value of PgR and HER2 on overall survival. In conclusion, IHC stainings for ER, PgR, and HER2 of just a single 1mm TMA core seems to be sufficient, as no significant heterogeneity was noticed.
Similar articles
-
Tissue microarray-based immunohistochemical study can significantly underestimate the expression of HER2 and progesterone receptor in ductal carcinoma in situ of the breast.Biotech Histochem. 2011 Oct;86(5):345-50. doi: 10.3109/10520295.2010.502845. Epub 2010 Aug 12. Biotech Histochem. 2011. PMID: 20701550
-
Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.J Clin Oncol. 2008 Mar 20;26(9):1419-26. doi: 10.1200/JCO.2007.14.5565. Epub 2008 Feb 19. J Clin Oncol. 2008. PMID: 18285604 Clinical Trial.
-
Loss of antigenicity in stored sections of breast cancer tissue microarrays.Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):667-72. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15066936
-
Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies.J Pathol. 2001 Sep;195(1):72-9. doi: 10.1002/path.893. J Pathol. 2001. PMID: 11568893 Review.
-
Pathology role in adjuvant setting.Cancer Treat Res. 2009;151:41-61. doi: 10.1007/978-0-387-75115-3_4. Cancer Treat Res. 2009. PMID: 19593505 Review. No abstract available.
Cited by
-
Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value.BMC Cancer. 2015 Jul 25;15:546. doi: 10.1186/s12885-015-1531-3. BMC Cancer. 2015. PMID: 26205655 Free PMC article.
-
Granulocyte Colony Stimulating Factor Expression in Breast Cancer and Its Association with Carbonic Anhydrase IX and Immune Checkpoints.Cancers (Basel). 2021 Mar 1;13(5):1022. doi: 10.3390/cancers13051022. Cancers (Basel). 2021. PMID: 33804486 Free PMC article.
-
The prognostic role of tissue TLR2 and TLR4 in colorectal cancer.Virchows Arch. 2020 Nov;477(5):705-715. doi: 10.1007/s00428-020-02833-5. Epub 2020 May 19. Virchows Arch. 2020. PMID: 32424768 Free PMC article.
-
Tissue microarray validation in cervical carcinoma studies. A methodological approach.Histol Histopathol. 2025 Mar;40(3):317-325. doi: 10.14670/HH-18-796. Epub 2024 Jul 16. Histol Histopathol. 2025. PMID: 39086316
-
Prognostic Impact of Urokinase Plasminogen Activator Receptor Expression in Pancreatic Cancer: Malignant Versus Stromal Cells.Biomark Insights. 2017 Jun 22;12:1177271917715443. doi: 10.1177/1177271917715443. eCollection 2017. Biomark Insights. 2017. PMID: 28690396 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous